Holoprosencephaly is a genetic and developmental condition that affects how the front of the brain and face form before birth. Features can include close-set eyes, cleft lip or palate, feeding or breathing problems, and seizures. Many babies with holoprosencephaly have serious medical needs, and severe forms can be life-limiting. Milder forms may be recognized later in infancy or childhood and can involve learning differences and hormonal issues. Care focuses on supportive treatments such as feeding support, seizure management, hormone replacement, and coordinated specialist care.
Overview
HoloprosencephalySymptoms
Early signs of Holoprosencephaly often appear before birth or at delivery. Signs can include midline facial differences (closely spaced eyes, cleft lip or palate, single central incisor), poor feeding, seizures, breathing or temperature problems, and developmental delay. Severity ranges widely.
Outlook and prognosis
Many living with holoprosencephaly do well with tailored care, though abilities and health needs vary widely. Early support for feeding, breathing, seizures, and development can improve comfort and skills. Lifespan ranges from infancy to adulthood, depending on type and complications.
Causes and risk factors
Holoprosencephaly usually results from chromosomal differences or single‑gene changes—often new, sometimes inherited. Risk increases with fetal trisomy 13, maternal diabetes, alcohol or retinoic acid exposure, and, rarely, infections. Family history and specific gene changes can raise recurrence risk.
Genetic influences
Genetics plays a major role in holoprosencephaly; many cases involve pathogenic variants in genes that guide early brain development. Inheritance can be autosomal dominant, recessive, or linked to chromosome changes, with variable expressivity and incomplete penetrance. Some cases remain unexplained or result from environmental factors.
Diagnosis
Doctors suspect holoprosencephaly from clinical features on prenatal ultrasound or brain MRI. Diagnosis of holoprosencephaly is confirmed with detailed imaging after birth and review of physical findings. Genetic diagnosis of holoprosencephaly uses chromosomal and gene tests to identify a cause.
Treatment and drugs
Treatment for holoprosencephaly focuses on comfort, safety, and supporting development. Care often blends seizure management, feeding support, hormone replacement if needed, and therapies for movement, speech, and vision, with surgery for specific issues like hydrocephalus or clefting. A coordinated team helps tailor care over time.
Symptoms
People with Holoprosencephaly can have a wide range of features that affect the face, feeding, breathing, and development. Some early features of Holoprosencephaly may be seen on prenatal ultrasound or noticed soon after birth, while milder forms are picked up later in childhood. Features vary from person to person and can change over time. For families, everyday tasks like feeding and sleep may need extra support.
In Holoprosencephaly, midline facial changes such as closely spaced eyes, a flat nasal bridge, or a cleft lip or palate are common. These can affect feeding, breathing through the nose, and later speech and dental development.
Babies may have a weak suck or trouble coordinating suck, swallow, and breathing. Meals can take longer and there’s a higher risk of coughing or choking.
Airway shape or tone differences can lead to noisy breathing or pauses in breathing. Colds can hit harder, and some children need monitoring during sleep.
Seizures are common in Holoprosencephaly. Episodes of staring, stiffening, or shaking can occur.
How people usually first notice Holoprosencephaly?
Many families first notice holoprosencephaly during pregnancy, when a routine ultrasound shows the baby’s brain hasn’t separated into two distinct halves or reveals facial differences such as closely spaced eyes, a single nostril, or a cleft lip/palate. Sometimes the first signs of holoprosencephaly appear at birth, with visible facial features and trouble breathing, feeding, or maintaining normal blood sugar, prompting urgent evaluation. In milder forms, how holoprosencephaly is first noticed may be slower head growth, seizures, or developmental delays in early infancy, leading doctors to confirm the diagnosis with brain imaging.
Types of Holoprosencephaly
Holoprosencephaly has several well-recognized clinical variants that differ mainly in how the front part of the brain separates early in development. These variants range from very severe to milder patterns, and facial differences often mirror what’s happening in the brain. Not everyone will experience every type. Clinicians often describe them in these categories:
Alobar type
The brain’s front sections do not separate, leading to a single large cavity. This is the most severe form and often comes with significant facial differences and serious medical needs. Many pregnancies with alobar holoprosencephaly end before birth or shortly after.
Semilobar type
There is partial separation of the brain’s front areas, with the back more separated than the front. This type is usually very serious but may have more defined brain structures than the alobar form. Feeding, breathing, and seizure challenges are common.
Lobar type
Most of the brain separates into two halves, but the front-most areas stay partially fused. Facial differences may be milder, and some children achieve limited developmental milestones. Medical and learning needs still vary widely.
Middle interhemispheric variant
The middle parts of the brain stay fused while the front and back separate more normally. This pattern is sometimes called syntelencephaly. Movement, muscle tone, and coordination differences often stand out more than facial changes.
Microform spectrum
Subtle features suggest very mild holoprosencephaly, sometimes with near-normal brain imaging. People may have small midline facial differences, like a single front tooth or a closely spaced nose and eye area. These very mild variants of holoprosencephaly can be found when evaluating relatives.
Facial-only forms
Facial differences consistent with holoprosencephaly appear without clear brain involvement on imaging. Examples include a single central incisor or midface underdevelopment. These types of holoprosencephaly highlight that facial features and brain separation often track together, but not always.
What genetics can tell you about symptoms
Some genetic changes in SHH, ZIC2, SIX3, or TGIF1 can disrupt early brain splitting, leading to a spectrum from severe facial differences and seizures to milder learning or hormonal issues. Extra or missing chromosome material, especially trisomy 13, often causes more severe forms.
Causes and risk factors
The main causes of holoprosencephaly are genetic changes and chromosome conditions that disrupt early brain development. Some risks are written in our DNA, passed down through families. Single gene changes or chromosome problems like trisomy 13 can cause holoprosencephaly, and many cases are new changes rather than inherited. Pregnancy factors also raise risk, including poorly controlled diabetes, alcohol, and certain acne medicines with vitamin A. These factors act in the first weeks of pregnancy, often before any early symptoms of Holoprosencephaly are noticed.
Environmental and biological risk factors
Holoprosencephaly develops very early in pregnancy, often before someone realizes they’re pregnant, so risk factors act during those first weeks. Doctors often group risks into internal (biological) and external (environmental). Parents often search for early symptoms of Holoprosencephaly, but these risks occur long before symptoms or features can be noticed on scans.
Pregnancies at older maternal ages carry a higher chance of holoprosencephaly. The likelihood increases with age because early embryo development is more prone to errors.
Holoprosencephaly is more likely when diabetes is present before pregnancy, especially if blood sugars are high around conception. Careful blood sugar control before and in the first weeks of pregnancy may lower this risk.
High-dose vitamin A derivatives (retinoic acid), such as some acne treatments, in early pregnancy have been linked to holoprosencephaly. These compounds can disrupt midline brain and face formation during the first month.
Significant high-dose radiation exposure in very early pregnancy can interfere with brain development. When exposure occurs in the first weeks after conception, the chance of severe midline differences, including holoprosencephaly, may increase.
Genetic risk factors
Families often ask why holoprosencephaly happens and what it means for future pregnancies. Many cases trace back to changes in chromosomes or in single genes that guide early brain development; when people discuss the genetic causes of holoprosencephaly, these are the main pathways. Risk is not destiny—it varies widely between individuals. Some changes are inherited, while others arise for the first time in a child, which affects recurrence risk.
Chromosome aneuploidy: Extra or missing whole chromosomes can disrupt early brain formation. Trisomy 13, trisomy 18, or triploidy are well-known examples linked to holoprosencephaly. These typically arise as new events and often carry low recurrence risk unless a parent has a chromosome rearrangement.
Copy-number variants: Small deletions or duplications of chromosome segments can remove or add key HPE genes. Regions such as 13q, 18p, and 7q36 (where SHH sits) are classic hotspots. Finding a copy-number change can clarify which gene pathway is involved.
Core HPE genes: Changes in SHH, ZIC2, SIX3, or TGIF1 can cause holoprosencephaly. These genes act like a dimmer switch for signals that tell the early brain how to split and pattern. The same change can look severe in one child and mild in another.
Other pathway genes: Variants in genes that relay SHH signals or related pathways (such as GLI2, PTCH1, FGFR1, FGF8, and others) can produce HPE or an HPE-like spectrum. Effects can include pituitary or facial differences even when the brain finding is subtle. Gene panels often group these together for testing.
Inherited or de novo: A change may be passed down from a parent or appear for the first time in a child. Many single-gene forms follow autosomal-dominant inheritance with reduced penetrance, so not every carrier shows HPE. This pattern explains why family history can look negative even when a genetic cause is present.
Variable expressivity: The same genetic change can cause a wide range of features, from classic HPE to only subtle facial differences. Some relatives may have learning or hormonal issues without known brain findings. This variability complicates prediction for future pregnancies.
Germline mosaicism: A parent can carry a genetic change in some egg or sperm cells but not in blood, called mosaicism. This can raise recurrence risk even when testing suggests a new (de novo) change in the child. Specialized testing and counseling help estimate this risk.
Balanced rearrangement: When a parent carries a balanced translocation or inversion involving HPE genes or regions, the chance of an unbalanced embryo increases. This can lead to holoprosencephaly in a future pregnancy. Parental chromosome studies can uncover this hidden risk.
Syndromic genetics: HPE can be one part of a broader genetic syndrome, such as Patau syndrome (trisomy 13) or Smith-Lemli-Opitz syndrome. In these conditions, the underlying gene or chromosome change drives multiple features across the body. Identifying a syndrome guides recurrence estimates and family screening.
Lifestyle risk factors
Holoprosencephaly is a congenital condition; lifestyle habits do not cause it, but daily care can influence symptoms, comfort, and complications. Understanding how lifestyle affects Holoprosencephaly helps caregivers prioritize routines that support feeding, breathing, movement, and sleep. Below are practical lifestyle risk factors for Holoprosencephaly that can worsen or ease day‑to‑day challenges.
Tailored textures and calorie-dense meals can reduce choking risk and support growth despite oromotor challenges. Poor intake or inappropriate textures may increase aspiration and hospitalizations.
Upright positioning and paced feeding can lower aspiration risk in children with dysphagia. Skipping safe-swallow strategies may worsen coughing, pneumonia, and poor weight gain.
Consistent sleep, medication timing, and trigger tracking can help reduce breakthrough seizures common in holoprosencephaly. Missed doses or irregular schedules may increase seizure frequency and injury risk.
Daily range-of-motion and supported sitting improve posture, reduce spasticity, and aid breathing mechanics. Inactivity may lead to contractures, pain, and respiratory compromise.
Risk prevention
Holoprosencephaly develops very early in pregnancy, so true prevention isn’t always possible. Different people need different prevention strategies—there’s no single formula. Still, there are steps that can lower risk before conception and in the first trimester, especially for those with known genetic factors or medical conditions. Planning ahead with your healthcare team is the most effective place to start.
Meet with a genetic counselor if holoprosencephaly runs in your family or you’ve had an affected pregnancy. They can review recurrence risk and discuss options for future pregnancies.
If you live with diabetes, aim for well-controlled blood sugar before conception and in early pregnancy. Good glucose control lowers several birth-defect risks, including the risk of holoprosencephaly.
Before trying to conceive, review all prescriptions, supplements, and acne or seizure medicines with your clinician. Some drugs, like isotretinoin and certain anti-seizure medicines, can raise birth-defect risks linked to holoprosencephaly, and safer alternatives may be available.
Avoid alcohol when trying to conceive and during pregnancy. Alcohol exposure in early pregnancy has been associated with brain and facial development problems, including patterns seen with holoprosencephaly.
Transmission
Holoprosencephaly is a congenital brain condition, not an infection, and it cannot be caught or spread between people. In some families, it results from a change in a single gene that can be passed from a parent; a parent may have subtle or no outward signs, yet still carry the gene change. Many cases happen as a new change in the baby’s genes at conception or from a chromosome difference, so there is no exposure or contact that transmits it. The chance of passing holoprosencephaly to a child depends on the exact genetic cause; when a parent carries the change, each pregnancy has some chance of inheriting it, and the effects can range from severe to very mild. If you’re wondering how holoprosencephaly is inherited, a genetics team can review the specific cause in your family and explain the recurrence risk.
When to test your genes
Holoprosencephaly is a genetic/congenital brain development condition; genetic testing is recommended when an ultrasound or MRI suggests HPE, after a pregnancy loss or birth with HPE, or when there’s a family history. Testing can clarify the cause, refine recurrence risk, and guide care. A genetics professional can tailor the right test.
Diagnosis
Holoprosencephaly is usually recognized by characteristic brain and facial features on prenatal or postnatal imaging, then confirmed with genetic tests. Genetic testing may be offered to clarify risk or guide treatment. The genetic diagnosis of Holoprosencephaly often combines what doctors see on scans with lab tests that look for chromosome changes or specific gene variants.
Sonographers look for how the front part of the baby’s brain is forming and whether it has split into two halves. They also check for midline facial differences that can go along with holoprosencephaly.
Detailed fetal MRI provides a clearer view of brain structure when ultrasound raises concern. It helps define the type and extent of holoprosencephaly to guide planning.
After birth, MRI gives high‑resolution images to confirm the diagnosis and subtype. It also helps distinguish holoprosencephaly from other brain malformations.
A head CT may be used if MRI isn’t available or safe at that moment. It can show overall brain structure but with less detail than MRI.
Stages of Holoprosencephaly
Holoprosencephaly does not have defined progression stages. It’s a structural brain difference that forms early in pregnancy and generally does not change over time; instead, clinicians describe severity at birth and tailor care to each child’s needs. Different tests may be suggested to help confirm the diagnosis and understand which body systems need support, such as prenatal ultrasound or MRI, newborn brain scans, and sometimes genetic testing. Monitoring often centers on early symptoms of holoprosencephaly—feeding or breathing difficulties, seizures, or hormone and blood sugar concerns—with regular follow-up from neurology, endocrine, vision, and feeding specialists.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with holoprosencephaly, the outlook depends on how severely the brain was affected before birth. Mild forms (often called microforms) may lead to subtle facial differences, learning challenges, or seizures but allow for long, meaningful lives with support. Moderate forms can bring feeding difficulties, hormone problems, developmental delays, and mobility issues that need ongoing care from neurology, endocrinology, and therapies. In the most severe forms, especially alobar holoprosencephaly, early mortality is common, with some infants not surviving the newborn period despite intensive care. Everyone’s journey looks a little different.
Over time, most people with holoprosencephaly who have milder involvement can reach personal milestones at their own pace and may attend school with accommodations; early symptoms of holoprosencephaly such as poor feeding, low muscle tone, or seizures often improve when therapies and medications are started early. Doctors call this the prognosis—a medical word for likely outcomes. Survival into childhood and adulthood is possible, particularly in lobar or semilobar types, though the risk of respiratory infections, dehydration, and seizure complications can raise hospital visits. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including the specific gene change (if present), access to coordinated care, nutrition, and seizure control. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Holoprosencephaly is present from birth, and the long-term picture depends on how fully the front of the brain separated during early development. Many children with the most severe forms face intensive medical needs and a high risk of early death, while those with milder forms may reach adolescence or adulthood. Long-term effects vary widely and can shift with growth, illness, and hormonal changes. People may not recall early symptoms of holoprosencephaly, but later features often mirror the same brain differences, affecting movement, learning, hormones, and the senses.
Global developmental delay and intellectual disability are common. Some learn basic skills slowly, while others remain dependent for most daily activities. Abilities can plateau or change with time.
Low or high muscle tone can affect posture and balance. Many have coordination challenges and delayed walking. Some use mobility aids long-term.
Epilepsy is frequent across severities. Seizure control can vary from well‑managed to difficult. Episodes may cluster with illness or growth spurts.
Ongoing difficulty coordinating suck, chew, and swallow can persist. Aspiration risk and poor weight gain may occur. Some require tube feeding for adequate nutrition.
How is it to live with Holoprosencephaly?
Living with holoprosencephaly can range from subtle learning and feeding challenges to profound disabilities that affect movement, speech, vision, breathing, and seizure control. Daily life often involves coordinated care—regular appointments with neurology, endocrinology, ENT, ophthalmology, physical and speech therapy—and careful attention to nutrition, airway safety, and seizure plans at home and school. Families and caregivers may experience emotional and practical strain, but many also build strong routines, use adaptive equipment, and lean on community services and respite care to create stability and moments of joy. For siblings, classmates, and friends, clear communication about abilities and needs helps foster inclusion and shared activities tailored to the child’s comfort and strengths.
Treatment and drugs
Treatment for holoprosencephaly focuses on easing symptoms, supporting development, and preventing complications, since there’s no single cure. Care is usually team-based and may include seizure medicines, therapy for feeding and breathing problems, hormone replacement if the pituitary is affected, and physical, occupational, and speech therapies to support daily function. Surgery may be considered for specific issues, such as severe hydrocephalus (fluid buildup), cleft lip or palate, or significant skull or facial differences that affect breathing or feeding. Not every treatment works the same way for every person, so plans are tailored to the child’s type of holoprosencephaly and individual needs, with close follow-up to adjust over time. Ask your doctor about the best starting point for you, including genetic counseling and supportive services for your family.
Non-drug treatment
Non-drug care for holoprosencephaly focuses on day-to-day needs like feeding, breathing, movement, communication, and comfort at home. Alongside medicines, non-drug therapies can support development, ease symptoms, and help families navigate care. Families may first notice early symptoms of holoprosencephaly such as poor feeding, low muscle tone, or unusual facial features, and these services aim to address those practical challenges. Plans are individualized and often change as children grow.
Structured programs, like state or regional early intervention services, can help build motor, communication, and self-care skills. Starting therapy in the first years often leads to steadier progress. Care usually happens at home or in familiar settings.
Guided exercises improve head control, balance, and mobility. Therapists teach safe positioning to reduce stiffness and prevent joint tightness. Home programs help families practice between visits.
Daily skills like feeding, grasping, and play are broken into small, achievable steps. Adaptive tools can make dressing and bathing safer and easier. Therapists also work on sensory comfort and calm routines.
Support includes early communication, from eye-gaze and gestures to sounds and words. Feeding and swallowing therapy helps reduce choking risk and improve nutrition. Some strategies can slip naturally into your routine—like pacing bites or using special nipples.
Your genes may have an impact on how drugs work for you
Medications used in holoprosencephaly care—such as antiseizure drugs or hormone therapies—can work differently depending on a child’s genes that affect drug breakdown and sensitivity. Pharmacogenetic testing, when available, may guide dosing and reduce side effects.
Pharmacological treatments
There’s no medication that corrects the brain development changes in holoprosencephaly, so medicines focus on easing symptoms and preventing complications. Not everyone responds to the same medication in the same way. Choices depend on age, severity, and which body systems are affected. Doses are individualized and adjusted over time as needs change.
Levetiracetam, valproic acid/divalproex, lamotrigine, and topiramate are common options. Dosing may be increased or lowered gradually to balance seizure control with side effects. If one option isn’t effective, second-line or alternative drugs may be offered.
Oral baclofen or diazepam can reduce muscle stiffness and spasms. Botulinum toxin injections may target tight muscle groups for more focused relief. Side effects, if they occur, can often be eased by dose adjustments.
Glycopyrrolate liquid/tablets or a scopolamine patch can reduce saliva production. Botulinum toxin injections into salivary glands may help when medicines aren’t enough. Dry mouth and constipation are common trade-offs to watch for.
Hydrocortisone, levothyroxine, desmopressin, or growth hormone may be needed when pituitary hormone levels are low. Doses aim to mimic natural body levels and support growth and energy. Regular blood and urine tests guide safe adjustments.
Genetic influences
Genetics often play a major role in Holoprosencephaly, though not every case is inherited. A change in a gene (mutation or variant) can sometimes affect health, and in holoprosencephaly these changes can disrupt early brain and facial development. Many cases are linked to chromosome differences—most commonly an extra copy of chromosome 13 (trisomy 13)—or small missing or extra segments of DNA. Others are due to single‑gene changes in key developmental genes (such as SHH, ZIC2, or SIX3), which may be passed from a parent or happen for the first time in the child. When inherited, a parent may have no symptoms or only very subtle features, so a family history can be easy to miss. Because the same gene change can lead to a wide range of outcomes, two relatives may be affected very differently. Genetic testing and counseling can help clarify the genetic causes of holoprosencephaly and provide clearer estimates of recurrence risk for future pregnancies.
Is Holoprosencephaly genetic?
Genetics plays a major role in holoprosencephaly; many cases involve pathogenic variants in genes that guide early brain development. Inheritance can be autosomal dominant, recessive, or linked to chromosome changes, with variable expressivity and incomplete penetrance. Some cases remain unexplained or result from environmental factors.
Pharmacogenetics—how genetics influence drug effects
For many living with holoprosencephaly, treatment focuses on seizures, hormone balance, feeding, and movement rather than one specific drug. The gene change that led to holoprosencephaly usually doesn’t control how medicines are broken down, but it can point to related issues—such as pituitary hormone shortages or clefting—that shape which therapies are needed and how closely to monitor them. Because anti-seizure medicines are often used, pharmacogenetic results can guide choices and doses: people who carry HLA-B*15:02 (more common in parts of Asia) or HLA-A*31:01 have a higher risk of severe skin reactions with carbamazepine or oxcarbazepine, while CYP2C9 or CYP2C19 differences can affect safe dosing of phenytoin or clobazam. For pain after procedures, CYP2D6 status can determine whether codeine or tramadol provide little relief or cause stronger-than-expected effects, so alternatives may be preferred in some cases. Reflux medicines like proton pump inhibitors may also work differently with CYP2C19 variants, leading doctors to adjust the dose or pick another option. Alongside medical history and current medicines, pharmacogenetic testing can be used to tailor these choices and reduce side effects. Genes are only part of the picture; age, liver and kidney function, feeding tolerance, and other medicines also shape the plan over time.
Interactions with other conditions
Living with holoprosencephaly often means managing other health issues at the same time, and the mix can affect day-to-day comfort and safety. Doctors call it a “comorbidity” when two conditions occur together. Seizures are common and can be harder to control if a child also has frequent infections, sleep disruption, or electrolyte imbalances from hormone problems. Feeding and swallowing difficulties may lead to reflux or food going into the airway, which raises the risk of chest infections and can strain breathing, especially during colds. Because the pituitary gland may not work normally, some people with holoprosencephaly develop hormone issues that affect growth, blood sugar, salt balance, and temperature; these changes can in turn trigger seizures or make recovery from illness slower. Holoprosencephaly can also be part of broader genetic syndromes linked to holoprosencephaly, such as those that include heart or kidney differences, so coordinated care helps ensure one treatment doesn’t worsen another condition.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with unusually close-set eyes, a single front tooth, or differences in the upper lip and nose—features we now recognize as part of holoprosencephaly. Midwives and physicians wrote brief notes about infants who struggled to feed or breathe and whose heads looked smaller than expected. Families noticed patterns: a relative lost several pregnancies, or more than one child was born with similar facial differences. Not every early description was complete, yet together they built the foundation of today’s knowledge.
First described in the medical literature as a problem of the “forebrain,” holoprosencephaly was initially understood through what doctors could see after birth or on examination after death. As microscopes and staining methods improved in the late 19th and early 20th centuries, pathologists documented how the front part of the brain had not fully divided into two halves. These careful drawings and case reports helped clinicians connect brain development with facial features, noting that the face and forebrain form around the same time in early pregnancy.
With the arrival of prenatal ultrasound in the 1970s and 1980s, clinicians could sometimes spot holoprosencephaly before birth. Images showed when the brain’s two hemispheres had not separated as expected, and doctors began to group cases by severity. Over time, descriptions became more precise, ranging from the most severe forms—where the brain remains largely as a single structure—to milder forms that may be noticed later in childhood because of learning differences, seizures, or subtle facial findings.
Advances in genetics in the 1990s and 2000s added another layer. Researchers identified changes in several genes involved in early head and brain formation and learned that the same genetic change can lead to different degrees of holoprosencephaly, even within one family. This variability helped explain why some pregnancies end early while others result in children with mild features who grow and learn with supports. It also showed that environmental factors—such as certain maternal health conditions or exposures—can interact with genetic susceptibility.
Today, the history of holoprosencephaly is a story of growing clarity. From early sketches and family stories to modern ultrasound, MRI, and genetic testing, each era has sharpened our understanding. Knowing the condition’s history helps explain why care plans now combine imaging, genetics, and supportive therapies, and why families are offered counseling that reflects both the range of outcomes and the hope that comes with early, coordinated care.